Project Grant R21AG087544

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $244K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This federal Project Grant award of $269,280 from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), supports research to determine the biological effects and antitumor activity of a senescent cell-targeted antibody, SIWA318, in preclinical models of pancreatic ductal adenocarcinoma (PDAC). The research aims to evaluate whether depletion of senescent and pro-fibrotic cells in the PDAC tumor microenvironment can improve the efficacy of standard-of-care...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $255,420 to the Trustees of the University of Pennsylvania to conduct research on balancing cellular repair and regeneration in aging and disease. The key objectives are to: Delineate the mechanism of Hedgehog signaling in balancing autophagy and proliferation to preserve cellular aging; Define the Hedgehog-dependent transcriptome during aging, with a focus on genes dysregulated in cancers...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a mechanistic understanding of the role of cellular senescence in the pathogenesis of Alzheimer's disease (AD). The $460,625 grant will fund research at the University of Massachusetts Medical School to dissect the separate P53/P21 and P16 senescence pathways and their functional consequences in AD using human induced pluripotent stem cell-based models. The 2-year project will produce...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $388,750 to The Washington University to conduct research on the role of senescent cancer-associated fibroblasts (senCAFs) in breast cancer progression. The key objectives are to: 1) Determine the organ-specific effects of senCAFs on metastatic breast cancer progression; 2) Examine how senCAFs impact extracellular matrix dynamics and tumor cell migration; and 3) Assess the impact of senCAFs on...
This Project Grant award from the National Institute on Aging (NIA, CFDA 93.866 Aging Research) provides $147,486 to Albert Einstein College of Medicine to study the role of chaperone-mediated autophagy (CMA) in cellular senescence and aging. The research aims to understand: 1) how CMA activity changes upon induction of senescence, 2) if CMA modulates the kinetics of senescence and by what mechanisms, 3) if CMA is required for clearance of senescent cells by the immune system, and 4) if...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $1,055,313 in funding to the University of Miami to conduct research on the role of glial cells in the aging process. Specifically, the researchers will leverage C. elegans genetics and advanced imaging and supplementation methods to investigate how the glial ion channel CLH-1 controls organismal aging. The key objectives are to establish the function of glial CLH-1 in influencing aging and to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,128,604.00 to The University of Texas MD Anderson Cancer Center to investigate the relationships between immunosenescence, brain aging biomarkers, and cognition across non-human primate species with differing lifespans. The project aims to elucidate the role of the immune system in longevity, neurodegeneration, and cognitive decline, which may inform the development of immuno-restorative...
The National Cancer Institute (NCI) awarded a $954,000 Project Grant (CFDA 93.396 - Cancer Biology Research) to the University of Pittsburgh to investigate how aging promotes the growth of glioblastoma, one of the most lethal forms of cancer. The research aims to leverage insights from the biology of neural stem cells and the molecular circuitry of cancer stem cells to understand how aging creates a tumor microenvironment that supports the survival and proliferation of glioblastoma. The...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $388,194 to The Johns Hopkins University to conduct research on "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for critical health challenges. The 3-year project, running from...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), is focused on identifying and characterizing clonal expansions that increase with age across various tissues, and understanding how these clonal mosaicism patterns are influenced by aging and age-related diseases. The $159,492 award to Weill Medical College of Cornell University aims to (1) develop tools to accurately identify somatic variants from publicly available...

This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $243,750 to the Sanford Burnham Prebys Medical Discovery Institute to conduct research on the impact of aging on the initiation and progression of pancreatic ductal adenocarcinoma (PDAC). The key objectives are to 1) examine how the aging stroma (tumor microenvironment) affects PDAC tumor growth and metastasis, and 2) investigate the influence of age on the intrinsic oncogenic potential of the pancreas. This 2-year award, running from September 1, 2024 to August 31, 2026, aims to establish new paradigms for studying PDAC and provide a patient-centric framework for evaluating potential PDAC therapies.

Generated 7/1/25, 2:09 AM